Assisted Reproduction: What Are the Real Risks to Women's Health

Assisted Reproduction: What Are the Real Risks to Women's Health

Publication date: 21-02-2025

Updated on: 21-02-2025

Topic: Gynaecology

Estimated reading time: 1 min

All couples preparing to undergo an Assisted Reproductive Technology (ART) process often have many doubts about the safety of treatments and the possible associated risks, as they are convinced that hormonal therapies might harm the future mother’s health.

"When we meet our patients for the first consultation, it is quite common for them to ask us about the side effects of hormonal therapies on women's health. These concerns are understandable, but they are often based on misinformation and may prevent couples from choosing a path that could help them fulfill their dream of parenthood," explains Dr. Mario Mignini Renzini, Director of the Gynecology Unit at Istituti Clinici Zucchi in Monza and Head of the Biogenesis Reproductive Medicine Center.

FIVET, ICSI, and the Risk of Tumors: Is There Really a Connection?

"When discussing hormonal therapies related to Assisted Reproductive Technology (ART) treatments, women sometimes express concerns about the possible effects on their health, including the risk of developing cancer," explains Dr. Mario Mignini Renzini.

"These treatments are often mistakenly referred to as "hormonal bombardment," a term that reflects widespread fears but does not accurately represent the nature or effects of the hormonal stimulation therapies used today. These treatments are not only safe but also tailored to the individual medical history of each patient.

When couples express doubts, I first explain that infertility itself is already a risk factor for certain types of cancer, such as breast, endometrial, and ovarian cancer."

Scientific Studies That Disprove a Link Between ART and Cancer

"The vast number of scientific studies on this topic demonstrate that there is no significant risk of developing these cancers as a result of fertility treatments," continues Dr. Mignini Renzini.

Specifically, a study published in the British Medical Journal ruled out the possibility that women undergoing ART treatments have a higher likelihood than others of developing breast, uterine, or ovarian cancer.

To reach this conclusion, researchers analyzed data from over 255,000 women who underwent ART procedures in the UK between 1991 and 2010. By cross-referencing this registry with the number of new cancer diagnoses recorded over an average follow-up period of eight years, they found no increased risk of invasive breast cancer or uterine cancer.

What Factors Actually Influence Cancer Risk?

"When discussing the risk of developing cancer, in women who have undergone one or more cycles of assisted reproduction, other factors can also play a role, such as:

  • Family history
  • Smoking
  • Diet
  • Obesity
  • The woman's age at the time of treatment

For these reasons, one essential aspect of safeguarding a patient's overall health is to follow a regular schedule of preventive check-ups, allowing for early detection and timely intervention in case of any emerging conditions," concludes Dr. Mignini Renzini.

ART Treatments and Early Menopause

"Another common fear related to assisted reproductive technology (ART) treatments is the risk of early menopause. However, it is important to clarify this issue and dispel this false myth," explains Dr. Lucia Maragno, Specialist in Gynecology and Obstetrics at the Biogenesis Reproductive Medicine Center of the Istituti Clinici Zucchi in Monza.

Menopause

A woman's reproductive ability is a complex mechanism regulated by numerous factors and, like the rest of the body, subject to aging. Each woman is born with a reserve of oocytes (an average of 2 million), which gradually decreases in both quantity and quality throughout her reproductive life, without regenerating.

When the ovarian reserve is depleted, the complex hormonal cycle that supports reproduction comes to an end, leading to menopause.

"The factors that determine the timing of menopause, explains Dr. Maragno, are:

  • The number of oocytes at birth
  • The rate at which they decrease
  • The minimum number of oocytes required for the menstrual cycle"

Why ART Does Not Cause Early Menopause

"Every month, a woman’s body initiates the maturation and growth of several oocytes, but only one is selected to fully mature," explains Dr. Maragno.

"Hormonal therapy, on the other hand, allows for the simultaneous maturation of all the recruited oocytes, including those that would not have completed the maturation process on their own.

Therefore, there is no risk of prematurely depleting a woman’s natural ovarian follicular reserve or inducing early menopause. The oocytes that mature due to ART treatments are the same ones that would have been lost during a normal menstrual cycle."

Read others

Cardiovascular diseases, Gynaecology
29-11-2024

Cardiovascular Diseases and Women's Reproductive History: What’s the Connection?

Gynaecology
26-11-2024

What is a Retroverted Uterus and How to recognize it?

Gynaecology
08-07-2024

What is the nuchal translucency scan and when is it done?